Lung Cancer
Conference Coverage
Durvalumab-Induced Hyperprogressive Disease in Non-Metastatic Lung Cancer
Conference Coverage
Cardiac Tamponade in a Patient with Stage IV Lung Adenocarcinoma Treated with Pembrolizumab
Conference Coverage
Use of Palliative Radiotherapy for Stage IV Lung Cancer Patients with Thoracic Symptoms in the Veterans Health Administration (VHA)
Article
Lung Cancer – Regional Snapshot Kansas City VA
Clinical Topics & News
Open Clinical Trials for Patients With Lung Cancers
News
HIV drug may enhance efficacy of chemoradiation in locally advanced lung cancer
Strategy incorporating protease inhibitor nelfinavir yields promising efficacy, acceptable toxicity in locally advanced non–small cell lung cancer...
Article
Timely Diagnosis of Lung Cancer in a Dedicated VA Referral Unit with Endobronchial Ultrasound Capability
A dedicated referral clinic with pulmonary consultation and aA dedicated referral clinic with pulmonary consultation and access to diagnostic...
News
Immune-related toxicities, hospitalization common with checkpoint inhibitor therapy
The most common immune-related adverse events warranting hospital admission were pneumonitis and colitis.
News
Bevacizumab or pemetrexed, but not both, efficacious for NSCLC maintenance
The combination of bevacizumab and pemetrexed did not improve survival and had significantly worse toxicity than bevacizumab alone.
News
COPD adds complexity to shared decision making for LDCT lung cancer screening
Current guidelines stress the importance of shared decision making, with discussion of the risks and benefits of screening.
